Analyst Price Targets — AZTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 1:14 pm | Vijay Kumar | Evercore ISI | $45.00 | $29.21 | TheFly | Azenta price target lowered to $45 from $50 at Evercore ISI |
| January 5, 2026 11:19 am | — | Evercore ISI | $50.00 | $33.39 | TheFly | Azenta upgraded to Outperform from In Line at Evercore ISI |
| December 19, 2025 12:46 pm | — | Needham | $44.00 | $34.50 | TheFly | Azenta price target raised to $44 from $42 at Needham |
| November 25, 2025 4:33 pm | Andrew Cooper | Raymond James | $45.00 | $36.64 | TheFly | Azenta price target raised to $45 from $35 at Raymond James |
| October 30, 2025 6:54 am | Matthew Stanton | Jefferies | $38.00 | $29.79 | StreetInsider | Jefferies Upgrades Azenta, Inc. (AZTA) to Buy |
| August 5, 2025 2:33 pm | Vijay Kumar | Evercore ISI | $33.00 | $26.90 | TheFly | Azenta price target lowered to $33 from $35 at Evercore ISI |
| April 4, 2024 2:42 am | Matthew Stanton | Jefferies | $64.00 | $59.01 | StreetInsider | Jefferies Starts Azenta, Inc. (AZTA) at Hold, 'Transformation Underway, But a Lot of Margin Runway Baked In' |
| January 3, 2023 7:12 am | — | Evercore ISI | $62.00 | $58.79 | Benzinga | Evercore ISI Group Downgrades Azenta to In-Line, Raises Price Target to $62 |
| November 15, 2022 5:51 am | — | Needham | $78.00 | $46.58 | Benzinga | Needham Maintains Buy on Azenta, Raises Price Target to $78 |
Latest News for AZTA
BURLINGTON, Mass., March 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom.
BURLINGTON, Mass., Feb. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond James 47th Annual Institutional Investor Conference, on Tuesday March 3rd, 2026, which includes a presentation beginning at 4:00 pm ET.
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Azenta, Inc. (NASDAQ: AZTA). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Azenta stock on January 15th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account. Representative Gilbert Ray
Azenta (NASDAQ: AZTA - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares Azenta and Mitesco"s
Caprock Group LLC bought a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,707 shares of the company's stock, valued at approximately $1,640,000. Caprock Group LLC owned about 0.12% of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AZTA.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.